Minerva Neurosciences, Inc.
NERV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001598646
No open-market purchases or sales by Minerva Neurosciences, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $234.8M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Minerva Neurosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −11 vs. Q3 2021
- Shares held
- 20.7M
- −3.93M (−15.9%) vs. Q3 2021
- Total value
- $16.6M
- −$26.3M (−61.3%) vs. Q3 2021
- New holders
- 3
- 5 more added
- Sold out
- 14
- 16 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NERV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $234.8M |
| Q1 2026 | 47 | $236.1M |
| Q4 2025 | 33 | $107.7M |
| Q3 2025 | 24 | $4.21M |
| Q2 2025 | 21 | $3.34M |
| Q1 2025 | 22 | $3.31M |
| Q4 2024 | 22 | $4.63M |
| Q3 2024 | 21 | $5.65M |
| Q2 2024 | 21 | $6.65M |
| Q1 2024 | 21 | $5.42M |
| Q4 2023 | 20 | $14.9M |
| Q3 2023 | 20 | $16.6M |
| Q2 2023 | 19 | $19.0M |
| Q1 2023 | 17 | $2.69M |
| Q4 2022 | 19 | $2.75M |
| Q3 2022 | 25 | $18.7M |
| Q2 2022 | 23 | $7.51M |
| Q1 2022 | 33 | $16.3M |
| Q4 2021 | 35 | $16.6M |
| Q3 2021 | 46 | $42.9M |
| Q2 2021 | 68 | $63.2M |
| Q1 2021 | 72 | $91.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Minerva Neurosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Federated Hermes, Inc. | 9,610,200 | $7.70M | 0.01% | 00.0% | Unchanged |
| Vanguard Group Inc | 4,025,746 | $3.23M | 0.00% | −76,417−1.9% | Reduced |
| Acadian Asset Management LLC | 1,768,685 | $1.41M | 0.01% | +58,202+3.4% | Added |
| Armistice Capital, LLC | 1,024,000 | $820.0K | 0.02% | +24,000+2.4% | Added |
| Millennium Management LLC | 799,398 | $640.0K | 0.00% | +19,977+2.6% | Added |
| Renaissance Technologies LLC | 591,100 | $473.0K | 0.00% | −163,016−21.6% | Reduced |
| BlackRock Inc. | 506,457 | $406.0K | 0.00% | +18,087+3.7% | Added |
| Geode Capital Management, LLC | 479,049 | $383.0K | 0.00% | −9,764−2.0% | Reduced |
| Dimensional Fund Advisors LP | 350,234 | $281.0K | 0.00% | −389,822−52.7% | Reduced |
| SEI Investments Co | 303,981 | $243.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 262,380 | $210.0K | 0.00% | −8,653−3.2% | Reduced |
| FMR LLC | 226,283 | $181.0K | 0.00% | −168,196−42.6% | Reduced |
| Bridgeway Capital Management, LLC | 178,911 | $143.0K | 0.00% | −10,289−5.4% | Reduced |
| Susquehanna International Group, LLP | 140,512 | $113.0K | 0.00% | −52,725−27.3% | Reduced |
| State Street Corp | 110,632 | $89.0K | 0.00% | 00.0% | Unchanged |
| D. E. Shaw & Co., Inc. | 100,161 | $80.0K | 0.00% | −89,895−47.3% | Reduced |
| Northern Trust Corp | 68,097 | $54.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 50,766 | $41.0K | 0.00% | −14,669−22.4% | Reduced |
| Virtu Financial LLC | 30,096 | $24.0K | 0.00% | −27,749−48.0% | Reduced |
| Bank of New York Mellon Corp | 19,705 | $16.0K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Services Advisors, Inc. | 20,000 | $16.0K | 0.00% | +3,000+17.6% | Added |
| Cambridge Investment Research Advisors, Inc. | 13,900 | $11.0K | 0.00% | −1,500−9.7% | Reduced |
| Sanders Morris Harris LLC | 12,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 10,795 | $9.00K | 0.00% | −31,211−74.3% | Reduced |
| Jane Street Group, LLC | 10,923 | $9.00K | 0.00% | +10,923 | New |
| Good Life Advisors, LLC | 10,000 | $8.00K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 9,400 | $7.00K | 0.00% | −83,152−89.8% | Reduced |
| Tower Research Capital LLC (TRC) | 8,046 | $6.00K | 0.00% | +8,046 | New |
| Aquatic Capital Management LLC | 2,200 | $2.00K | 0.00% | +2,200 | New |
| Bank of America Corp | 832 | $1.00K | 0.00% | −7,389−89.9% | Reduced |
| TFC Financial Management | 1,488 | $1.00K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 533 | $427 | 0.00% | −46−7.9% | Reduced |
| Anchor Investment Management, LLC | 100 | $80 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 750 | $0 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 17 | $0 | 0.00% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −1,082,333−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −487,140−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −480,629−100.0% | Sold out |
| Highland Capital Management Fund Advisors, L.P. | 0 | $0 | 0.00% | −400,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −143,761−100.0% | Sold out |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −95,744−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −56,300−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −48,865−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −39,190−100.0% | Sold out |
| Palo Alto Investors LP | 0 | $0 | 0.00% | −36,319−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −33,559−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −17,295−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,788−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −5,045−100.0% | Sold out |